A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK, the Measure of How the Human Body Processes a Substance) of ETX0282 When Administered Orally to Healthy Participants
Clinical trial NCT03491748 · COMPLETED
Trial details
- NCT number
- NCT03491748
- Sponsor
- Entasis Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-16
- Primary completion
- 2019-09-11
- Enrollment
- 99
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.